Literature DB >> 32302248

ACEing COVID-19: A Role for Angiotensin Axis Inhibition in SARS-CoV-2 Infection?

Venkatesh L Murthy1, Milka Koupenova2, Ravi V Shah3.   

Abstract

Entities:  

Keywords:  COVID-19; Editorials; angiotensin II; hypertension; infections

Mesh：

Substances：

Year:  2020        PMID： 32302248      PMCID： PMC7274880          DOI： 10.1161/CIRCRESAHA.120.317174

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  13 in total

1.  Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.

Authors:  María Paz Ocaranza; Ivan Godoy; Jorge E Jalil; Manuel Varas; Patricia Collantes; Melissa Pinto; Maritza Roman; Cristián Ramirez; Miguel Copaja; Guillermo Diaz-Araya; Pablo Castro; Sergio Lavandero
Journal:  Hypertension       Date:  2006-08-14       Impact factor: 10.190

2.  Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

Authors:  Carlos M Ferrario; Jewell Jessup; Mark C Chappell; David B Averill; K Bridget Brosnihan; E Ann Tallant; Debra I Diz; Patricia E Gallagher
Journal:  Circulation       Date:  2005-05-16       Impact factor: 29.690

3.  Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.

Authors:  I Hamming; H van Goor; A J Turner; C A Rushworth; A A Michaud; P Corvol; G Navis
Journal:  Exp Physiol       Date:  2008-01-11       Impact factor: 2.969

4.  Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.

Authors:  Biykem Bozkurt; Richard Kovacs; Bob Harrington
Journal:  J Card Fail       Date:  2020-05       Impact factor: 5.712

5.  Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.

Authors:  Peng Zhang; Lihua Zhu; Jingjing Cai; Fang Lei; Juan-Juan Qin; Jing Xie; Ye-Mao Liu; Yan-Ci Zhao; Xuewei Huang; Lijin Lin; Meng Xia; Ming-Ming Chen; Xu Cheng; Xiao Zhang; Deliang Guo; Yuanyuan Peng; Yan-Xiao Ji; Jing Chen; Zhi-Gang She; Yibin Wang; Qingbo Xu; Renfu Tan; Haitao Wang; Jun Lin; Pengcheng Luo; Shouzhi Fu; Hongbin Cai; Ping Ye; Bing Xiao; Weiming Mao; Liming Liu; Youqin Yan; Mingyu Liu; Manhua Chen; Xiao-Jing Zhang; Xinghuan Wang; Rhian M Touyz; Jiahong Xia; Bing-Hong Zhang; Xiaodong Huang; Yufeng Yuan; Rohit Loomba; Peter P Liu; Hongliang Li
Journal:  Circ Res       Date:  2020-04-17       Impact factor: 17.367

6.  SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?

Authors:  Gabriela M Kuster; Otmar Pfister; Thilo Burkard; Qian Zhou; Raphael Twerenbold; Philip Haaf; Andreas F Widmer; Stefan Osswald
Journal:  Eur Heart J       Date:  2020-05-14       Impact factor: 29.983

7.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

8.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

Authors:  I Hamming; W Timens; M L C Bulthuis; A T Lely; G J Navis; H van Goor
Journal:  J Pathol       Date:  2004-06       Impact factor: 7.996

9.  SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS.

Authors:  G Y Oudit; Z Kassiri; C Jiang; P P Liu; S M Poutanen; J M Penninger; J Butany
Journal:  Eur J Clin Invest       Date:  2009-05-06       Impact factor: 4.686

10.  Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.

Authors:  Zhen Zou; Yiwu Yan; Yuelong Shu; Rongbao Gao; Yang Sun; Xiao Li; Xiangwu Ju; Zhu Liang; Qiang Liu; Yan Zhao; Feng Guo; Tian Bai; Zongsheng Han; Jindong Zhu; Huandi Zhou; Fengming Huang; Chang Li; Huijun Lu; Ning Li; Dangsheng Li; Ningyi Jin; Josef M Penninger; Chengyu Jiang
Journal:  Nat Commun       Date:  2014-05-06       Impact factor: 14.919
View more
  6 in total

1.  Navigating migraine care through the COVID-19 pandemic: an update.

Authors:  Heather Angus-Leppan; Angelica E Guiloff; Karen Benson; Roberto J Guiloff
Journal:  J Neurol       Date:  2021-05-17       Impact factor: 4.849

2.  Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".

Authors:  Jordana B Cohen; Thomas C Hanff; Andrew M South; Matthew A Sparks; Swapnil Hiremath; Adam P Bress; J Brian Byrd; Julio A Chirinos
Journal:  Circ Res       Date:  2020-06-04       Impact factor: 17.367

Review 3.  Cardiovascular system and coronavirus disease-2019 (COVID-19): mutual injuries and unexpected outcomes.

Authors:  Eman Sobh; Muhammad Saad Reihan; Tamer M S Hifnawy; Khloud Gamal Abdelsalam; Sohaila Sabry Awad; Nehal Mostafa Hamed Mahmoud; Nariman A Sindi; Hani A Alhadrami
Journal:  Egypt Heart J       Date:  2021-09-03

4.  Coronavirus-19: Possible Therapeutic Implications of Spironolactone and Dry Extract of Glycyrrhiza glabra L. (Licorice).

Authors:  Decio Armanini; Cristina Fiore; Jens Bielenberg; Chiara Sabbadin; Luciana Bordin
Journal:  Front Pharmacol       Date:  2020-10-22       Impact factor: 5.810

5.  Association between renin-angiotensin-aldosterone system inhibitor use and COVID-19 hospitalization and death: a 1.4 million patient nationwide registry analysis.

Authors:  Gianluigi Savarese; Lina Benson; Johan Sundström; Lars H Lund
Journal:  Eur J Heart Fail       Date:  2020-12-07       Impact factor: 17.349

Review 6.  Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational studies, and clinical implications.

Authors:  Filippos Triposkiadis; Randall C Starling; Andrew Xanthopoulos; Javed Butler; Harisios Boudoulas
Journal:  Heart Fail Rev       Date:  2020-09-01       Impact factor: 4.214
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.